How do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients?
G Wong, FB Sime, J Lipman, JA Roberts - BMC infectious diseases, 2014 - Springer
High mortality and morbidity rates associated with severe infections in the critically ill
continue to be a significant issue for the healthcare system. In view of the diverse and …
continue to be a significant issue for the healthcare system. In view of the diverse and …
Linezolid-based regimens for multidrug-resistant tuberculosis (TB): a systematic review to establish or revise the current recommended dose for TB treatment
MS Bolhuis, OW Akkerman… - Clinical Infectious …, 2018 - academic.oup.com
Linezolid has been successfully used for treatment of multidrug-resistant tuberculosis (MDR-
TB). However, dose-and duration-related toxicity limit its use. Here, our aim was to search …
TB). However, dose-and duration-related toxicity limit its use. Here, our aim was to search …
Linezolid in the treatment of drug-resistant tuberculosis: the challenge of its narrow therapeutic index
S Wasserman, G Meintjes… - Expert review of anti …, 2016 - Taylor & Francis
Introduction: Linezolid is an oxazolidinone with potent activity against M tuberculosis, and
improves culture conversion and cure rates when added to treatment regimens for drug …
improves culture conversion and cure rates when added to treatment regimens for drug …
Alternative methods for therapeutic drug monitoring and dose adjustment of tuberculosis treatment in clinical settings: a systematic review
PS Rao, N Modi, NTT Nguyen, DH Vu, YL Xie… - Clinical …, 2023 - Springer
Abstract Background and Objective Quantifying exposure to drugs for personalized dose
adjustment is of critical importance in patients with tuberculosis who may be at risk of …
adjustment is of critical importance in patients with tuberculosis who may be at risk of …
LC-MS/MS for therapeutic drug monitoring of anti-infective drugs
A Veringa, MGG Sturkenboom, BGJ Dekkers… - TrAC Trends in …, 2016 - Elsevier
Therapeutic drug monitoring (TDM) is a tool used to integrate pharmacokinetic and
pharmacodynamic knowledge to optimise and personalize drug therapy. TDM is of specific …
pharmacodynamic knowledge to optimise and personalize drug therapy. TDM is of specific …
Drug monitoring and individual dose optimization of antimicrobial drugs: oxazolidinones
Introduction: Oxazolidinones are synthetic antibiotics with bacteriostatic activity against
Gram-positive pathogens. Linezolid, the first marketed oxazolidinone, has shown also …
Gram-positive pathogens. Linezolid, the first marketed oxazolidinone, has shown also …
Systematic review of salivary versus blood concentrations of antituberculosis drugs and their potential for salivary therapeutic drug monitoring
SHJ van den Elsen, LM Oostenbrink… - Therapeutic drug …, 2018 - journals.lww.com
Background: Therapeutic drug monitoring is useful in the treatment of tuberculosis to assure
adequate exposure, minimize antibiotic resistance, and reduce toxicity. Salivary therapeutic …
adequate exposure, minimize antibiotic resistance, and reduce toxicity. Salivary therapeutic …
Air assisted dispersive liquid-liquid microextraction with solidification of the floating organic droplets (AA-DLLME-SFO) and UHPLC-PDA method: Application to …
V Ferrone, R Cotellese, M Carlucci, L Di Marco… - … of pharmaceutical and …, 2018 - Elsevier
An ultra high-performance liquid chromatographic (UHPLC) method with PDA detection was
developed and validated for the simultaneous quantification of metronidazole, meropenem …
developed and validated for the simultaneous quantification of metronidazole, meropenem …
Saliva-based linezolid monitoring on a mobile UV spectrophotometer
HY Kim, E Ruiter, EM Jongedijk, HK Ak… - Journal of …, 2021 - academic.oup.com
Background In TB, therapeutic drug monitoring (TDM) is recommended for linezolid;
however, implementation is challenging in endemic settings. Non-invasive saliva sampling …
however, implementation is challenging in endemic settings. Non-invasive saliva sampling …
[HTML][HTML] Push forward LC-MS-based therapeutic drug monitoring and pharmacometabolomics for anti-tuberculosis precision dosing and comprehensive clinical …
The spread of tuberculosis (TB), especially multidrug-resistant TB and extensively drug-
resistant TB, has strongly motivated the research and development of new anti-TB drugs …
resistant TB, has strongly motivated the research and development of new anti-TB drugs …